HK1205677A1 - Mesenchymal stem cells and uses therefor - Google Patents
Mesenchymal stem cells and uses thereforInfo
- Publication number
- HK1205677A1 HK1205677A1 HK15106166.8A HK15106166A HK1205677A1 HK 1205677 A1 HK1205677 A1 HK 1205677A1 HK 15106166 A HK15106166 A HK 15106166A HK 1205677 A1 HK1205677 A1 HK 1205677A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- stem cells
- mesenchymal stem
- methods
- animal
- uses therefor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0663—Bone marrow mesenchymal stem cells (BM-MSC)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
To provide novel uses of mesenchymal stem cells.SOLUTION: The present invention discloses methods for treating animal autoimmune diseases, allergic diseases, cancer, or inflammatory diseases, methods for promoting wound healing, and methods promoting angiogenesis in animal organs and tissues by administering an effective amount of animal mesenchymal stem cells.SELECTED DRAWING: None
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55511804P | 2004-03-22 | 2004-03-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1205677A1 true HK1205677A1 (en) | 2015-12-24 |
Family
ID=46060822
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15106165.9A HK1205531A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
| HK15106166.8A HK1205677A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15106165.9A HK1205531A1 (en) | 2004-03-22 | 2015-06-29 | Mesenchymal stem cells and uses therefor |
Country Status (6)
| Country | Link |
|---|---|
| JP (8) | JP6114500B2 (en) |
| AT (1) | ATE556134T1 (en) |
| CA (3) | CA2868733C (en) |
| ES (7) | ES2708627T3 (en) |
| HK (2) | HK1205531A1 (en) |
| TR (1) | TR201901268T4 (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR201901268T4 (en) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mesenchymal stem cells and their uses. |
| CA2873968A1 (en) * | 2012-05-16 | 2014-06-26 | Kennedy Krieger Institute, Inc. | Stem cells as an individualized maternal therapy for prevention of prematurity |
| JP2016210730A (en) * | 2015-05-08 | 2016-12-15 | 上田 実 | Pharmaceutical compositions and production methods thereof as well as pharmaceuticals |
| CN109952371A (en) | 2016-11-15 | 2019-06-28 | 株式会社钟化 | Cell mass, preparation method and medical composition comprising the mesenchyma lineage stem cells from fetal appendage |
| JP7454379B2 (en) | 2017-12-28 | 2024-03-22 | 株式会社カネカ | Cell population containing adherent stem cells, method for producing the same, and pharmaceutical composition |
| EP3984596A4 (en) | 2019-06-14 | 2023-06-21 | Kaneka Corporation | Cell population including mesenchymal cells, pharmaceutical composition including same, and method for producing same |
| AU2020330745A1 (en) * | 2019-08-15 | 2022-03-24 | Nextcell Pharma Ab | Allogeneic composition for treatment of CNS disorders |
| CN113813288B (en) * | 2021-08-11 | 2024-02-13 | 谢岩 | Application of mesenchymal stem cells and composition containing mesenchymal stem cells in preparation of medicine for treating burn wound difficult to heal |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0651641B2 (en) * | 1983-08-29 | 1994-07-06 | 株式会社ミドリ十字 | Gamma interferon composition |
| EP0302862A1 (en) * | 1986-03-17 | 1989-02-15 | Schering Corporation | Treatment of cancers with gamma interferon |
| WO1995034320A2 (en) * | 1994-06-07 | 1995-12-21 | Regents Of The University Of Minnesota | Methods for inhibiting antigen specific t cell responses |
| US6497875B1 (en) * | 1996-04-26 | 2002-12-24 | Case Western Reserve University | Multilayer skin or dermal equivalent having a layer containing mesenchymal stem cells |
| US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| ATE316795T1 (en) * | 1998-03-18 | 2006-02-15 | Osiris Therapeutics Inc | MESENCHYMAL STEM CELLS FOR THE PREVENTION AND TREATMENT OF IMMUNE RESPONSE DURING TRANSPLANTATIONS |
| DK1066060T3 (en) * | 1998-04-03 | 2003-11-24 | Osiris Therapeutics Inc | Mesenchymal stem cells as immunosuppressive agents |
| AU2925401A (en) * | 2000-01-19 | 2001-07-31 | Parkash S Gill | Methods and compositions for antisense vegf oligonucleotides |
| DE60143517D1 (en) * | 2000-04-25 | 2011-01-05 | Osiris Therapeutics Inc | RESTORING THE RACES WITH MESENCHYMAL STEM CELLS |
| NZ533987A (en) * | 2002-02-01 | 2007-04-27 | Schering Corp | Uses of mammalian cytokine; agonists and antagonists for modulating antigen presenting cell priming of T cells |
| JP3897343B2 (en) * | 2002-08-01 | 2007-03-22 | 株式会社林原生物化学研究所 | Protein that induces production of interferon-γ in immunocompetent cells |
| US20040258670A1 (en) * | 2002-12-05 | 2004-12-23 | Case Western Reserve University | Cell-based therapies for ischemia |
| TR201901268T4 (en) * | 2004-03-22 | 2019-02-21 | Mesoblast Int Sarl | Mesenchymal stem cells and their uses. |
| EP2298863B1 (en) * | 2004-03-22 | 2015-07-22 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
-
2005
- 2005-03-15 TR TR2019/01268T patent/TR201901268T4/en unknown
- 2005-03-15 ES ES14172800T patent/ES2708627T3/en active Active
- 2005-03-15 ES ES10011225.9T patent/ES2544689T3/en active Active
- 2005-03-15 ES ES14172807T patent/ES2657382T5/en active Active
- 2005-03-15 CA CA2868733A patent/CA2868733C/en active Active
- 2005-03-15 CA CA3135582A patent/CA3135582A1/en active Pending
- 2005-03-15 ES ES05725577T patent/ES2385450T3/en active Active
- 2005-03-15 AT AT05725577T patent/ATE556134T1/en active
- 2005-03-15 ES ES10011223.4T patent/ES2643030T3/en active Active
- 2005-03-15 ES ES10011224.2T patent/ES2643076T3/en active Active
- 2005-03-15 ES ES10011226.7T patent/ES2645018T3/en active Active
- 2005-03-15 CA CA2934682A patent/CA2934682C/en active Active
-
2012
- 2012-03-15 JP JP2012058539A patent/JP6114500B2/en active Active
-
2014
- 2014-11-28 JP JP2014241859A patent/JP5997237B2/en active Active
-
2015
- 2015-06-29 HK HK15106165.9A patent/HK1205531A1/en unknown
- 2015-06-29 HK HK15106166.8A patent/HK1205677A1/en unknown
-
2017
- 2017-01-13 JP JP2017003854A patent/JP6382360B2/en active Active
- 2017-08-10 JP JP2017155229A patent/JP6757300B2/en active Active
-
2018
- 2018-10-09 JP JP2018190636A patent/JP6757383B2/en active Active
-
2020
- 2020-03-18 JP JP2020047240A patent/JP7033159B2/en active Active
-
2021
- 2021-08-30 JP JP2021140167A patent/JP2021191771A/en active Pending
-
2023
- 2023-02-20 JP JP2023023996A patent/JP2023065486A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2018009002A (en) | 2018-01-18 |
| ES2643030T3 (en) | 2017-11-21 |
| ES2385450T3 (en) | 2012-07-25 |
| CA2934682A1 (en) | 2005-10-06 |
| JP6382360B2 (en) | 2018-08-29 |
| HK1205531A1 (en) | 2015-12-18 |
| CA2868733C (en) | 2019-12-17 |
| JP7033159B2 (en) | 2022-03-09 |
| CA2868733A1 (en) | 2005-10-06 |
| TR201901268T4 (en) | 2019-02-21 |
| JP6757300B2 (en) | 2020-09-16 |
| ES2645018T3 (en) | 2017-12-01 |
| JP2021191771A (en) | 2021-12-16 |
| JP2020111591A (en) | 2020-07-27 |
| JP2019014747A (en) | 2019-01-31 |
| ES2708627T3 (en) | 2019-04-10 |
| JP2012176948A (en) | 2012-09-13 |
| CA2934682C (en) | 2021-12-07 |
| ES2657382T3 (en) | 2018-03-05 |
| JP2023065486A (en) | 2023-05-12 |
| ES2544689T3 (en) | 2015-09-02 |
| JP5997237B2 (en) | 2016-09-28 |
| ES2643076T3 (en) | 2017-11-21 |
| ATE556134T1 (en) | 2012-05-15 |
| JP2017080507A (en) | 2017-05-18 |
| JP6757383B2 (en) | 2020-09-16 |
| JP6114500B2 (en) | 2017-04-12 |
| CA3135582A1 (en) | 2005-10-06 |
| ES2657382T5 (en) | 2021-07-12 |
| JP2015061862A (en) | 2015-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1205677A1 (en) | Mesenchymal stem cells and uses therefor | |
| EP2298861A3 (en) | Mesenchymal stem cells and uses therefor | |
| WO2008116157A3 (en) | Mesenchymal stem cells and uses therefor | |
| EA200700175A1 (en) | COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY DISEASES | |
| ATE489957T1 (en) | AGENTS FOR THE TREATMENT OF INFLAMMATORY DISEASES | |
| MX2007004551A (en) | Thiadiazole compounds and methods of use. | |
| TW200738657A (en) | Thiazole compounds and methods of use | |
| TW200732347A (en) | VEGF analogs and methods of use | |
| SG158112A1 (en) | Hepatocyte growth factor (hgf) binding proteins | |
| BR0308928A (en) | Use of botulinum toxin for the treatment of cardiovascular disease, as well as composition for use in a cardiovascular procedure. | |
| CY1118073T1 (en) | COMPOSITIONS AND METHODS FOR INCREASING THE TELECOMMUNICATION ACT | |
| HK1122803A1 (en) | ||
| AR061170A1 (en) | PROTEINS THAT JOIN THE HEPATOCITE GROWTH FACTOR (HGF) | |
| TW200833330A (en) | Substituted dihydropyrazolones and their use | |
| MY158100A (en) | 6,9-disubstituted purine derivatives and their use for treating skin | |
| DE602005026866D1 (en) | USE OF THREE-DIMENSIONAL CULTURED TISSUE FOR THE TREATMENT OF CONGESTIVE HEART FAILURE | |
| ITMI20041550A1 (en) | USE OF PROBIOTIC BACTERIA FOR THE PREPARATION OF TOPICAL COMPOSITIONS FOR THE PROTECTION OF THE EPIDERMIS | |
| MX2007010484A (en) | Molecules and methods of using same for treating mcp-1/ccr2 associated diseases. | |
| HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
| CY1111353T1 (en) | USE OF KALALIDIS COMPOUNDS FOR PRODUCTION OF MEDICINE FOR TREATMENT OF PORCELAIN | |
| DE602006011959D1 (en) | NA +, K + -ATPASE EXPRESSION IN ZERVIX DYSPLASIA AND CANCER | |
| MX2011009277A (en) | Activated leukocyte composition. | |
| WO2007055760A3 (en) | Protein composition for promoting wound healing and skin regeneration | |
| WO2011091154A3 (en) | Use of human erythrocytes for prevention and treatment of cancer dissemination and growth | |
| EA200701598A1 (en) | METHOD AND COMPOSITION FOR RESTORING EPITELIAL AND OTHER CELLS AND TISSUES |